DiaGenic ASA
Industry
- Miscellaneous
See more in Biomedtracker
Latest on DiaGenic ASA
In Vivo
IN VITRO DIAGNOSTICS Mergers & Acquisitions Abingdon Health Ltd. Molecular Vision Ltd. Abingdon Health Ltd. has purchased a 50.1% equity stake in fellow private diagnostics firm Molecular Vision
Medtech Insight
Mergers & Acquisitions Alliances Financings Elsevier’s Strategic Transactions
Medtech Insight
Mergers & Acquisitions AdnaGen AG & OncoVista Innovative Therapies Inc. OncoVista Innovative Therapies Inc. (cancer biomarkers and personalized therapeutics) is selling the 78% that it owns of its